Abstract
During development as well as in pathological situations, neurons that fail to find appropriate targets or neurotrophic factors undergo cell death. Using primary cortical neurons subjected to acute serum-deprivation (SD), we have examined caspases activation, mitochondrial dysfunction and cell death parameters. Among a panel of metabolic, signaling and caspases inhibitors only those able to interfere with caspase-2 like activity protect primary neurons against SD-induced cell death. In situ detection and subcellular fractionation demonstrate a very early activation of cytosolic caspase-2, which controls Bax cleavage, relocalization and mitochondrial membrane permeabilization (MMP). Both z-VDVAD-fmk and a siRNA specific for caspase-2 abolish Bax changes, mitochondrial membranes permeabilization, as well as cytochrome c release-dependent activation of caspase-9/caspase-3, nuclear alterations, phosphatidylserine exposure, neurites dismantling and neuronal death. Hence, caspase-2 is an early checkpoint for apoptosis initiation in primary neurons subjected to serum deprivation.
Similar content being viewed by others
Abbreviations
- 7-AAD:
-
7-Amino Actinomycin D
- ALLM:
-
N- Acetyl-Leu-Leu-Met-al
- ALLN:
-
N-Acetyl-Leu-Leu-Norleu-al
- BAPTA-AM:
-
acetoxymethyl ester of 1, 2-bis(2-aminophenoxy) ethane-N,N,N′,N′-tetraacetic acid
- BOC-D-FMK:
-
BOC-Asp (OMe)-fluoromethylketone
- mClCCP:
-
carbonylcyanide m- chlorophenylhydrazone
- CMXRos:
-
Mito
Tracker® Red CMXRos
- ΔΨ m :
-
mitochondrial transmembrane potential
- DIDS:
-
4,4′-Diisothiocyanastilbene-2,2′-disulfonic acid disodium salt
- E64d:
-
trans-Epoxysuccinyl-L-leucylamido-(4- guanidine)butane
- FLICA:
-
Fluorochrome-Labeled Inhibitor of Caspase; FC: flow cytometry
- FM:
-
fluorescence micro- scopy
- JC-1:
-
5,5′,6,6′-tetrachloro-1,1′, 3,3′-tetraethyl- benzimidazolylcarbocyanine iodide
- MMP:
-
mitochondrial membrane permeabilization
- MPTP:
-
1-methyl-4-phenyl-1,2, 3,6-tetrahydropyridine
- NA:
-
nuclear apoptosis
- Pefabloc SC®:
-
4-(2-Aminoethyl)-benzenesulfonyl fluoride
- SD:
-
serum deprivation
- PS:
-
phosphatidyl-serine
- PTP:
-
permeability transition pore
- Q-VD-OPH:
-
Quinoline-Val-Asp (OMe)-CH2-O-Ph, Q-VD-OPH; Z-DEVD-FMK; N-benzyloxycarbonyl-Asp-Glu(Ome)-His-Asp(Ome)-fluoromethylketone
- Z-FA-FMK;:
-
N-ben- zyloxycarbonyl-Phe-Ala-fluoromethylketone
- z-FF-fmk:
-
N- benzyloxycarbonyl-Phe-Phe-fluoromethylketone
- Z-LEHD-:
-
FMK: N-ben-zyloxycarbonyl-Leu-Glu(Ome)-His-Asp(OMe)-fluoromethylketone
- Z-LETD-FMK:
-
N-benzyloxycarbonyl-Leu-Glu(Ome)-Thr-Asp(OMe)-fluoromethylketone
- Z-VAD-FMK:
-
N-benzyloxycarbonyl-Val-Ala-Asp(Ome)-fluoromethylketone
- Z-VDVAD-FMK:
-
N-benzyloxycarbonyl-Val-Asp(Ome)-Val-Ala-Asp(OMe)-fluoromethylketone
- VDAC:
-
voltage-dependent-anionic-channel
References
Lipton P. Ischemic cell death in brain neurons. Physiol Rev 1999; 79: 1431–1568.
Yuan J, Yankner B. Apoptosis in the nervous system. Nature 2000; 407: 802–809.
Mattson MP. Apoptosis in neurodegenerative disorders. Nat Rev Mol Cell Biol 2000; 1: 120–129.
Nicholls DG, Budd SL. Mitochondria and neuronal survival. Physiol Rev 2000; 80: 315–360.
Yuan J, Lipinski M, Degterev A. Diversity in the mechanisms of neuronal cell death. Neuron 2003; 40: 401–413.
Rideout HJ, Stefanis L. Caspase inhibition: A potential therapeutic strategy in neurological diseases. Histol Histopathol 2001; 16: 895–908.
Nicotera P. Apoptosis and age-related disorders: Role of caspase-dependent and caspase-independent pathways. Toxicol Letters 2002; 127: 189–195.
Orrenius S, Zhivotovsky B, Nicotera P. Calcium: Regulation of cell death: the calcium–apoptosis link. Nat Rev Mol Cell Biol 2003; 4: 552–565.
McLaughlin B, Hartnett KA, Erhardt JA, et al. Caspase 3 activation is essential for neuroprotection in preconditioning. Proc Natl Acad Sci USA 2003; 100: 715–720.
Hartmann A, Hunot S, Michel PP, et al. Caspase-3: A vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson's disease. Proc Natl Acad Sci USA 2000; 97: 2875–2880.
Mogi M, Togari A, Kondo T, et al. Caspase activities and tumor necrosis factor receptor R1 (p55) level are elevated in the substantia nigra from parkinsonian brain. J Neural Transm 2000; 107: 335–341.
Gastard MC, Troncoso JC, Koliatsos VE. Caspase activation in the limbic cortex of subjects with early Alzheimer's disease. Ann Neurol 2003; 54, 393–398.
Chan SL, Mattson ML. Caspase and calpain substrates: roles in synaptic plasticity and cell death. J Neurosci Res 1999; 58: 167–190.
Deshmukh M, Vasilakos J, Deckwerth TL, et al. Genetic and metabolic status of NGF-deprived sympathetic neurons saved by an inhibitor of ICE family proteases. J Cell Biol 1996; 135: 1341–1354.
Lassus P, Opitz-Araya X, Lazebnik Y. Requirement for caspase-2 in stress-induced apoptosis before mitochondrial permeabilization. Science 2002; 297: 1352–1354.
Robertson JD, Enoksson M, Suomela M, et al. Caspase-2 acts upstream of mitochondria to promote cytochrome c release during etoposide-induced apoptosis. J Biol Chem 2002; 277: 29803–29809.
Robertson JD, Gogvadze V, Kropotov A, et al. Processed caspase-2 can induce mitochondria-mediated apoptosis independently of its enzymatic activity. EMBO Rep 2004; 5: 643–648.
Troy CM, Shelanski ML. Caspase-2 redux. Cell Death Differ 2003; 10: 101–107.
Troy CM, Stefanis L, Greene LA, et al. Nedd2 is required for apoptosis after trophic factor withdrawal, but not superoxide dismutase (SOD1) downregulation in sympathetic neurons and PC12 cells. J Neurosci 1997; 17: 1911–1918.
Troy CM, Rabacchi SA, Friedman WJ, et al. Caspase-2 mediates neuronal cell death induced by beta-amyloid. J Neurosci 2000; 20: 1386–1392.
Haviv R, Lindenboim L, Yuan J, Stein R. Need for caspase-2 in apoptosis of growth-factor-deprived PC12 cells. J Neurosci Res 1998; 52: 491–497.
Stefanis L, Troy CM, Qi H, et al. Inhibitors of trypsin-like serine proteases inhibit processing of the caspase Nedd-2 and protect PC12 cells and sympathetic neurons from death evoked by withdrawal of trophic support. J Neurochem 1997; 69: 1425–1437.
Stefanis L, Troy CM, Qi H, et al. Caspase-2 (Nedd-2) processing and death of trophic factor-deprived PC12 cells and sympathetic neurons occur independently of caspase-3 (CPP32)-like activity. J Neurosci 1998; 18: 9204–9215.
Troy CM, Rabacchi SA, Xu Z, et al. Beta-Amyloid-induced neuronal apoptosis requires c-Jun N-terminal kinase activation. J Neurochem 2001; 77: 157–164.
Bergeron L, Perez GI, Macdonald G, et al. Defects in regulation of apoptosis in caspase-2-deficient mice. Genes Dev 1998; 12: 1304–1314.
Hermel E, Gafni J, Propp SS, et al. Specific caspase interactions and amplification are involved in selective neuronal vulnerability in Huntington's disease. Cell Death Differ 2004; 11: 424–438.
Li H, Bergeron L, Cryns V, et al. Activation of caspase-2 in apoptosis. J Biol Chem 1997; 272: 21010–21017.
Lecoeur H, Chauvier D, Langonné A, et al. Fixed- and real-time cytofluorometric technologies for dynamic analysis of apoptosis in primary cortical neurons. Apoptosis 2004; 9: 157–169.
Susin SA, Lorenzo H, Zamzami N, et al. Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 1999; 397: 441–446.
Poser S, Impey S, Xia Z, et al. Brain-derived neurotrophic factor protection of cortical neurons from serum withdrawal-induced apoptosis is inhibited by cAMP. J Neurosci 2003; 23: 4420–4427.
Caserta TM, Smith AN, Gultice AD, et al. Q-VD-OPh, a broad spectrum caspase inhibitor with potent antiapoptotic properties. Apoptosis 2003; 8: 345–352.
Stefanis L, Park DS, Yan CY, et al. Induction of CPP32-like activity in PC12 cells by withdrawal of trophic support. Dissociation from apoptosis. J Biol Chem 1996; 271: 30663–30671.
Deshmukh M, Kuida K, Johnson EM Jr. Caspase inhibition extends the commitment to neuronal death beyond cytochrome c release to the point of mitochondrial depolarization. J Cell Biol 2000; 150: 131–143.
Deckwerth TL, Elliott JL, Knudson CM, et al. BAX is required for neuronal death after trophic factor deprivation and during development. Neuron 1996; 17: 401–411.
Deshmukh M, Johnson EM. Evidence of a novel event during neuronal death: development of competence-to-die in response to cytoplasmic cytochrome c. Neuron 1998; 21: 695–705.
Putcha GV, Deshmukh M, Johnson EM. BAX translocation is a critical event in neuronal apoptosis: regulation by neuroprotectants, BCL-2, and caspases. J Neurosci 1999; 19: 7476–7485.
Karpinich NO, Tafani M, Rothman RJ. The course of etoposide-induced apoptosis from damage to DNA and p53 activation to mitochondrial release of cytochrome c. J Biol Chem 2002; 277: 16547–1652.
Tafani M, Cohn JA, Karpinich NO, et al. Regulation of intracellular pH mediates Bax activation in HeLa cells treated with staurosporine or tumor necrosis factor-alpha. J Biol Chem 2002; 277: 49569–49576.
Guo Y, Srinivasula SM, Druilhe A, et al. Caspase-2 induces apoptosis by releasing proapoptotic proteins from mitochondria. J Biol Chem 2002; 277: 13430–13437.
Wood DE, Thomas A, Devi LA, et al. Bax cleavage is mediated by calpain during drug-induced apoptosis. Oncogene 1998; 17: 1069–1078.
Choi WS, Lee EH, Chung CW, et al. Cleavage of Bax is mediated by caspase-dependent or -independent calpain activation in dopaminergic neuronal cells: protective role of Bcl-2. J Neurochem 2001; 77: 1531–1541.
Marsden VS, Ekert PG, Van Delft M, et al. Bcl-2-regulated apoptosis and cytochrome c release can occur independently of both caspase-2 and caspase-9. J Cell Biol 2004, 165; 775–780.
Troy CM, Rabacchi SA, Hohl JB, et al. Death in the balance: alternative participation of the caspase-2 and -9 pathways in neuronal death induced by nerve growth factor deprivation. J Neurosci 2001; 21: 5007–5016.
Henshall DC, Skradski SL, Bonislawski DP, et al. Caspase-2 activation is redundant during seizure-induced neuronal death. J Neurochem 2001; 77: 886–895.
Ekert PG., Read SH, Silke J, et al. Apaf-1 and caspase-9 accelerate apoptosis, but do not determine whether factor-deprived or drug-treated cells die. J Cell Biol 2004; 165, 835–842.
Qin Y, Van den Hoek TL, Wojcik K, et al. Caspase-dependent cytochrome c release and cell death in chick cardiomyocytes following simulated ischemia-reperfusion. Am J Physiol Heart Circ Physiol 2004; 286: H2280–2286.
Wang L, Miura M, Bergeron L, et al. Ich-1, an Ice/ced-3-related gene, encodes both positive and negative regulators of programmed cell death. Cell 1994; 78, 739–750.
Adrain C, Creagh EM, Martin SJ. Apoptosis-associated release of Smac/DIABLO from mitochondria requires active caspases and is blocked by Bcl-2. EMBO J 2001; 20: 6627–6636.
Paroni G, Henderson C, Schneider C. Caspase-2-induced apoptosis is dependent on caspase-9, but its processing during UV- or tumor necrosis factor-dependent cell death requires caspase-3. J Biol Chem 2001; 276: 21907–21915.
Prokop A, Wrasidlo W, Lode H, et al. Induction of apoptosis by enediyne antibiotic calicheamicin thetaII proceeds through a caspase-mediated mitochondrial amplification loop in an entirely Bax-dependent manner. Oncogene 2003; 22: 9107–9120.
Paroni G, Henderson C, Schneider C, et al. Caspase-2 can trigger cytochrome c release and apoptosis from the nucleus. J Biol Chem 2002; 277: 15147–15161.
Colussi PA, Harvey NL, Kumar S. Prodomain-dependent nuclear localization of the caspase-2 (Nedd2) precursor. A novel function for a caspase prodomain. J Biol Chem 1998; 273: 24535–24542.
Susin SA, Lorenzo H, Zamzami N, et al. Mitochondrial release of caspase-2 and -9 during the apoptotic process. J Exp Med 1999; 189: 381–394.
O'Reilly LA, Ekert P, Harvey N, et al. Caspase-2 is not required for thymocyte or neuronal apoptosis even though cleavage of caspase-2 is dependent on both Apaf-1 and caspase-9. Cell Death Differ 2002; 9: 832–841.
Mancini M, Machamer CE, Roy S, et al. Caspase-2 is localized at the Golgi complex and cleaves golgin-160 during apoptosis. J Cell Biol 2000; 149: 603–612.
Ohtsuka T, Ryu H, Minamishima YA, et al. ASC is a Bax adaptor and regulates the p53-Bax mitochondrial apoptosis pathway. Nat Cell Biol 2004; 6: 121–128.
Baliga BC, Colussi PA, Read SH, et al. Role of prodomain in importin-mediated nuclear localization and activation of caspase-2. J Biol Chem 2003; 278: 4899–4905.
Wood DE, Newcomb EW. Cleavage of Bax enhances its cell death function. Exp Cell Res 2000; 256: 375–382.
Cao X, Deng X, May WS. Cleavage of Bax to p18 Bax accelerates stress-induced apoptosis, and a cathepsin-like protease may rapidly degrade p18 Bax. Blood 2003; 102: 2605–2614.
Sawada M, Hayes P, Matsuyama S. Cytoprotective membrane-permeable peptides designed from the Bax-binding domain of Ku70. Nat Cell Biol 2003; 5: 352–357.
Guo B, Zhai D, Cabezas E, et al. Humanin peptide suppresses apoptosis by interfering with Bax activation. Nature 2003; 423: 456–461.
Ohtsuka T, Ryu H, Minamishima YA, et al. ASC is a Bax adaptor and regulates the p53-Bax mitochondrial apoptosis pathway. Nat Cell Biol 2004; 6, 121–128.
Author information
Authors and Affiliations
Corresponding author
Additional information
D. Rebouillat and E. Jacotot share senior co-authorship.
Rights and permissions
About this article
Cite this article
Chauvier, D., Lecoeur, H., Langonné, A. et al. Upstream control of apoptosis by caspase-2 in serum-deprived primary neurons. Apoptosis 10, 1243–1259 (2005). https://doi.org/10.1007/s10495-005-1681-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10495-005-1681-x